Who is sponsoring NCT04770909?

NCT04770909 is sponsored by University of Wisconsin, Madison.

What drugs are being tested in NCT04770909?

Interventions in NCT04770909: Incentives for dietary self-monitoring and weight loss, Incentives for dietary self-monitoring, Incentives for weight loss.

Is NCT04770909 still recruiting?

NCT04770909 is currently completed. Last updated 4 May 2025.

Last reviewed 2025-05-04 · How we verify

NCT04770909

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Log2Lose: Incenting Weight Loss and Dietary Self-monitoring in Real-time to Improve Weight Management Among Adults With Obesity

Completed NA Last updated 4 May 2025

What this trial tests

NA trial testing Incentives for dietary self-monitoring and weight loss in Obesity in 706 participants. Completed in 10 April 2025.

Timeline

13 May 2021

Primary endpoint
8 April 2024

10 April 2025

Quick facts

Lead sponsor	University of Wisconsin, Madison
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	treatment
Enrollment	706
Start date	13 May 2021
Primary completion	8 April 2024
Estimated completion	10 April 2025
Sites	2 locations across United States

Drugs / interventions tested

Incentives for dietary self-monitoring and weight loss
Incentives for dietary self-monitoring
Incentives for weight loss

Conditions studied

Obesity — all drugs for Obesity →

Sponsor

University of Wisconsin, Madison

Who can join

18 and older, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study involves an evaluation of whether providing small incentives weekly for dietary self-monitoring and/or weight loss improves short- and long-term weight loss. Participants can expect to be on study for 18 months.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Study protocol for Log2Lose: A randomized controlled trial to evaluate financial incentives for dietary self-monitoring and interim weight loss in adults with obesity.
Voils CI, Gierisch JM, Pendergast JF, Davenport CA, et al · · 2025 · cited 1× · PMID 40774423 · DOI 10.1016/j.cct.2025.108042
Development, Challenges, and Evolution of the Log2Lose Intervention for Weight Management: Randomized Controlled Digital Health Trial.
Shaw RJ, Miller H, Barnes C, Davenport C, et al · · 2025 · PMID 41248493 · DOI 10.2196/70842

Verify or expand the search:

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other University of Wisconsin, Madison trials

Trials by the same sponsor.

NCT07440004 — Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts · Phase 1 · recruiting
NCT07278466 — The COMParing App Support Strategies Study · NA · recruiting
NCT07475104 — Redesigning Surgical Care for Patients in Wisconsin · NA · enrolling by invitation
NCT07470723 — The ORIGIN-FH Study · NA · recruiting
NCT06975657 — Well-being Skills for Reentry · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04770909 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Wisconsin, Madison
Last refreshed: 4 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04770909.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing